We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Salesforce
CRM
$155B
| $12.5M | 0.07% |
45,864
-22,943
| -33% | -$6.13M |
|
377
Axalta
AXTA
$7.99B
| $12.5M | 0.07% |
+420,945
| New | +$13.1M |
|
378
Accenture
ACN
$101B
| $12.4M | 0.07% |
41,582
-146,717
| -78% | -$44.7M |
|
379
Lamb Weston
LW
$7.25B
| $12.4M | 0.07% |
239,058
+71,181
| +42% | +$3.81M |
|
380
PENN Entertainment
PENN
$2.7B
| $12.2M | 0.06% |
+682,547
| New | +$10.7M |
|
381
Loar Holdings
LOAR
$6.9B
| $12.2M | 0.06% |
141,210
+105,062
| +291% | +$9.09M |
|
382
Teva Pharmaceuticals
TEVA
$39.9B
| $12.1M | 0.06% |
724,910
-319,700
| -31% | -$5.16M |
|
|
ETNB
383
DELISTED
89bio
ETNB
| $12M | 0.06% |
1,222,661
+521,907
| +74% | +$4.32M |
|
384
LKQ Corp
LKQ
$5.94B
| $12M | 0.06% |
324,317
-13,447
| -4% | -$536K |
|
385
Biogen
BIIB
$29.8B
| $12M | 0.06% |
95,560
-29,602
| -24% | -$3.69M |
|
386
Ulta Beauty
ULTA
$23.3B
| $12M | 0.06% |
+25,629
| New | +$10.6M |
|
387
Teledyne Technologies
TDY
$31.6B
| $11.9M | 0.06% |
+23,253
| New | +$11.2M |
|
388
Blackstone
BX
$109B
| $11.8M | 0.06% |
78,925
+17,088
| +28% | +$2.35M |
|
389
Arrowhead Research
ARWR
$12.3B
| $11.8M | 0.06% |
746,156
+183,981
| +33% | +$2.64M |
|
|
CRCL
390
Circle Internet Group
CRCL
$15.4B
| $11.8M | 0.06% |
+65,000
| New | +$10.6M |
|
391
Gartner
IT
$11.7B
| $11.6M | 0.06% |
+28,595
| New | +$12M |
|
|
MAZE
392
Maze Therapeutics
MAZE
$1.52B
| $11.5M | 0.06% |
940,700
+11,598
| +1% | +$121K |
|
393
Erie Indemnity
ERIE
$12.4B
| $11.5M | 0.06% |
+33,202
| New | +$12.3M |
|
|
INFA
394
DELISTED
Informatica
INFA
| $11.5M | 0.06% |
472,302
+452,769
| +2,318% | +$9.34M |
|
395
Pinterest
PINS
$14.1B
| $11.5M | 0.06% |
+319,561
| New | +$9.7M |
|
396
Enovis
ENOV
$1.79B
| $11.4M | 0.06% |
364,895
| – | – |
|
397
Intellia Therapeutics
NTLA
$1.53B
| $11.4M | 0.06% |
1,219,068
+1,194,962
| +4,957% | +$9.81M |
|
|
MTSR
398
DELISTED
Metsera Inc
MTSR
| $11.4M | 0.06% |
400,785
+100,568
| +33% | +$2.5M |
|
399
Viridian Therapeutics
VRDN
$2.21B
| $11.4M | 0.06% |
815,485
+1,838
| +0.2% | +$24.9K |
|
400
Intercontinental Exchange
ICE
$83.7B
| $11.4M | 0.06% |
62,048
+13,505
| +28% | +$2.32M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.